advertisement
Wang N 42
Showing records 1 to 25 | Display all abstracts from Wang N108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Song Y
Journal of Glaucoma 2023; 32: 563-568
107730 Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury
Yang Y
Cell Death and Disease 2023; 14: 92
107970 New insight of metabolomics in ocular diseases in the context of 3P medicine
Zhang Q
The EPMA Journal 2023; 14: 53-71
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Liu H
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Shi Y
British Journal of Ophthalmology 2023; 107: 221-226
107970 New insight of metabolomics in ocular diseases in the context of 3P medicine
Wang N
The EPMA Journal 2023; 14: 53-71
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Oatts J
British Journal of Ophthalmology 2023; 107: 221-226
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Zhu X
Journal of Glaucoma 2023; 32: 563-568
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Li R
The Lancet. Global health 2023; 11: e456-e465
107730 Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury
Wang N; Xu L
Cell Death and Disease 2023; 14: 92
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Tian J
British Journal of Ophthalmology 2023; 107: 221-226
107970 New insight of metabolomics in ocular diseases in the context of 3P medicine
Rui Y
The EPMA Journal 2023; 14: 53-71
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Zhang Y
The Lancet. Global health 2023; 11: e456-e465
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Qiao C
British Journal of Ophthalmology 2023; 107: 221-226
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Zhang K
The Lancet. Global health 2023; 11: e456-e465
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Shu J
Journal of Glaucoma 2023; 32: 563-568
107730 Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury
Liu Y
Cell Death and Disease 2023; 14: 92
107970 New insight of metabolomics in ocular diseases in the context of 3P medicine
Xia Y; Xiong S
The EPMA Journal 2023; 14: 53-71
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Yusufu M
The Lancet. Global health 2023; 11: e456-e465
107730 Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury
Huang L
Cell Death and Disease 2023; 14: 92
106968 Low-dose transscleral cyclophotocoagulation with subsequent phacoemulsification in the treatment of prolonged acute primary angle closure
Zhang Q
British Journal of Ophthalmology 2023; 107: 221-226
108376 Outcomes of Partial Versus Complete Goniotomy With or Without Phacoemulsification for Primary Open Angle Glaucoma: A Multicenter Study
Dang G
Journal of Glaucoma 2023; 32: 563-568
107596 Economic evaluation of combined population-based screening for multiple blindness-causing eye diseases in China: a cost-effectiveness analysis
Liu Y
The Lancet. Global health 2023; 11: e456-e465
107970 New insight of metabolomics in ocular diseases in the context of 3P medicine
Xia X
The EPMA Journal 2023; 14: 53-71
107730 Aryl hydrocarbon receptor dependent anti-inflammation and neuroprotective effects of tryptophan metabolites on retinal ischemia/reperfusion injury
Gu M
Cell Death and Disease 2023; 14: 92
